InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by PELLETIER SAUNDRA L, Chairman & CEO. Insider active across 3 companies, notably Evofem Biosciences, Inc.. Aggregated, 12 disclosures have been published. Total volume traded: €263k. The latest transaction was filed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€46,308141,000 shares@ €0.32845.38% mcap15.7% of flow
Common Stock
SEC:0001618835-22-000130:0·
Ideal exit: 21 Feb 2023 (T+270)
0750,000 shares0
Common Stock
SEC:0001618835-22-000028:0·
0300,000 shares0
Common Stock
SEC:0001618835-22-000004·
0300,000 shares0
Common Stock
SEC:0001618835-22-000004:0·
€45,026135,000 shares@ €0.33355.23% mcap51.6% of flow
Common Stock
SEC:0001618835-21-000271·
Ideal exit: 16 Sept 2022 (T+270)
€45,026135,000 shares@ €0.33355.23% mcap15.3% of flow
Common Stock
SEC:0001618835-21-000271:0·
Ideal exit: 16 Sept 2022 (T+270)
€21,1746,545 shares@ €3.2352100.0% of flow
Common Stock
SEC:0001209191-21-048272·
Ideal exit: 22 Apr 2022 (T+270)
€21,1746,545 shares@ €3.235250.0% of flow
Common Stock
SEC:0001209191-21-048272:0·
Ideal exit: 22 Apr 2022 (T+270)
€42,30850,000 shares@ €0.84624.91% mcap14.3% of flow
Common Stock
SEC:0001618835-21-000147:0·
Ideal exit: 7 Mar 2022 (T+270)
€42,30850,000 shares@ €0.84624.91% mcap48.4% of flow
Common Stock
SEC:0001618835-21-000147·
Ideal exit: 7 Mar 2022 (T+270)
€74,074105,300 shares@ €0.7035100.0% of flow
Common Stock
SEC:0001618835-21-000133·
€74,074105,300 shares@ €0.70358.60% mcap25.1% of flow
Common Stock
SEC:0001618835-21-000133:0·
12 of 12 declarations
About PELLETIER SAUNDRA L
Saundra L. Pelletier is the Chairman & CEO of Evofem Biosciences, Inc. and Tracon Pharmaceuticals, Inc. She also serves as a Director at these companies. Her responsibilities include strategic and operational leadership, aiming to maximize shareholder value and ensure sustainable growth.
